Presently, fibrin sealant is an emerging industry. However, there are only limited manufacturers who are actually involved in the technological research of fibrin selants that are capable of clinical feasibility. The major factor that is all set to drive the fibrin sealant market is the increase in the number of ambulatory surgical centers. These centers are low-priced as well as easily available to patients. Also, ambulatory surgeries do not necessitate overnight hospital stays. The growing fame of ambulatory surgical centers has augmented the amount of patients, which consequently aggregate the number of surgeries being performed. Furthermore, owing to the increase in surgeries, the demand for wound closure products which include fibrin sealants has also experienced an upsurge. Huge pool of patients drives the market in evolving countries.
SAMPLE FIGURE: FIBRIN SEALANTS CLASSIFICATION, BY KEY SEGMENTS
Source: Publisher's Analysis and Expert Insights
The global market for fibrin sealants was estimated to be $XX billion in 2015. The global market for fibrin sealants is estimated to grow at a CAGR of XX% and is forecast to reach $XX billion by 2021. The fibrin sealants are forecast to have the highest growth of XX% during the forecast period 2016-2021. Americas and APAC together are estimated to occupy a share of more than XX% in 2015.
The application segment is the major driver for the fibrin sealants market to grow. Fibrin sealants find their applications in various segments like cardiovascular surgery, thoracic surgery, neurosurgery, orthopedic Surgery, plastic and reconstructive surgery and more. North America dominated the global fibrin sealants market. The medical development in this region is all set to drive the demand of fibrin sealant materials. Major players involved in this market are mainly concentrating on R&D initiatives and new product developments to cater the needs of customers. Moreover, booming medical industry will directly impact the demand of the fibrin sealants over the foreseeable period.
SAMPLE FIGURE: FIBRIN SEALANTS REVENUE, BY GEOGRAPHY, 2015(%)
Source: Publisher's Analysis, Expert Insights
Americas dominates the fibrin glue or sealant market owing to large aging population and growth in number of surgical procedures. Additionally, China and India are the fastest growing fibrin sealants market in APAC region followed by Europe and RoW. Fibrin sealants market to have highest growth in the next few years due to advance in technology and increasing aging population. Americas accounts to XX% of the global market for fibrin sealants in 2015 and is the fastest growing market followed by APAC.
The global fibrin sealants market is evaluated based on key attributes such as technology, application and others. Each of the segmentations in the report has been studied to give comprehensive analysis of global fibrin sealants market. The overall market has also been consolidated from the perspective of different geographic locations into standard geographic regions and key economies for this market. Additionally, this report encompasses opportunity analysis, porter analysis, pricing analysis and market forces such as drivers, constraints and challenges that are involved to drive the overall market.
The key players profiled in this report are Quantum OPS, Bayer AG and others. This report gives detailed information about the product value chain right from the beginning which includes raw materials till end-use. The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants. The study includes the demand of this particular market on a global and regional scale for a six year period of 2016-2021, both in terms of volume(kilo tons) and revenue($ million).
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Fibrin Sealants Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user Profiling
3.2.3. Top 5 Financials Analysis
4. Fibrin Sealants Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.3. Attractiveness of the Fibrin Sealants
4.3.1. Power of Suppliers
4.3.2. Threats From New Entrants
4.3.3. Power of Buyer
4.3.4. Threat From Substitute Product
4.3.5. Degree of Competition
5. Fibrin Sealants-Strategic Analysis
5.1. Fibrin Sealants - Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle
5.5. Suppliers and Distributors
5.6. SWOT Analysis
6. Fibrin Sealants - By Technology
6.1. Viral Inactivation
6.2. Autologous Donation
6.3. Recombinant Production
7. Fibrin Sealants-By Application
7.1. Cardiovascular Surgery
7.2. Thoracic Surgery
7.4. Orthopaedic Surgery
7.5. Plastic And Reconstructive Surgery
7.6. Dental Surgery
8. Fibrin Sealants -By Geography
8.3.2. South Korea
8.4. Rest of The World (RoW)
9. Fibrin Sealants Entropy
9.1. New Product Developments
9.2. Mergers and Acquisitions
10. Company Profiles
10.1. Ethicon US, LLC
10.3. The Medicines Company
10.4. Baxter International Inc
10.5. Biegler GmbH
10.6. LifeBond LTD
10.7. Tissuemed Ltd.
10.8. Integra LifeSciences Corporation
10.9. Cohera Medical, Inc
10.10. Surgical Specialties Corporation
10.11. OCULAR THERAPEUTIX, INC.
10.12. AccessClosure, Inc.
10.13. Cryolife, Inc.
10.14. Haemacure Corporation
10.15. HyperBranch Medical Technology
10.16. Neomend, Inc.
10.17. Omrix Biopharmaceuticals Inc.
10.18. Vascular Solutions, Inc.
10.19. Vivostat A/S
10.20. Z-Medica Corporation
10.21. Zymogenetics, Inc.
10.22. SurgRx, Inc.
10.23. GTC Biotherapeutics
10.24. Possis Medical
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"